BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 38338365)

  • 21. In Silico Analysis Revealed a Unique Binding but Ineffective Mode of Amantadine to Influenza Virus B M2 Channel.
    Zhang Y; Zheng QC
    J Phys Chem Lett; 2021 Feb; 12(4):1169-1174. PubMed ID: 33480694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influenza B virus M2 protein can functionally replace its influenza A virus counterpart in promoting virus replication.
    Wanitchang A; Wongthida P; Jongkaewwattana A
    Virology; 2016 Nov; 498():99-108. PubMed ID: 27567258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-resolution structures of the M2 channel from influenza A virus reveal dynamic pathways for proton stabilization and transduction.
    Thomaston JL; Alfonso-Prieto M; Woldeyes RA; Fraser JS; Klein ML; Fiorin G; DeGrado WF
    Proc Natl Acad Sci U S A; 2015 Nov; 112(46):14260-5. PubMed ID: 26578770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influenza M2 proton channels.
    Pielak RM; Chou JJ
    Biochim Biophys Acta; 2011 Feb; 1808(2):522-9. PubMed ID: 20451491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Structure, Function, and Pathobiology of the Influenza A and B Virus Ion Channels.
    Lamb RA
    Cold Spring Harb Perspect Med; 2020 Nov; 10(11):. PubMed ID: 31988204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influenza B virus BM2 protein is a crucial component for incorporation of viral ribonucleoprotein complex into virions during virus assembly.
    Imai M; Watanabe S; Ninomiya A; Obuchi M; Odagiri T
    J Virol; 2004 Oct; 78(20):11007-15. PubMed ID: 15452221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influenza A M2 Inhibitor Binding Understood through Mechanisms of Excess Proton Stabilization and Channel Dynamics.
    Watkins LC; DeGrado WF; Voth GA
    J Am Chem Soc; 2020 Oct; 142(41):17425-17433. PubMed ID: 32933245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An amantadine-sensitive chimeric BM2 ion channel of influenza B virus has implications for the mechanism of drug inhibition.
    Ohigashi Y; Ma C; Jing X; Balannick V; Pinto LH; Lamb RA
    Proc Natl Acad Sci U S A; 2009 Nov; 106(44):18775-9. PubMed ID: 19841275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced incorporation of the influenza B virus BM2 protein in virus particles decreases infectivity.
    Jackson D; Zürcher T; Barclay W
    Virology; 2004 May; 322(2):276-85. PubMed ID: 15110525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. XFEL structures of the influenza M2 proton channel: Room temperature water networks and insights into proton conduction.
    Thomaston JL; Woldeyes RA; Nakane T; Yamashita A; Tanaka T; Koiwai K; Brewster AS; Barad BA; Chen Y; Lemmin T; Uervirojnangkoorn M; Arima T; Kobayashi J; Masuda T; Suzuki M; Sugahara M; Sauter NK; Tanaka R; Nureki O; Tono K; Joti Y; Nango E; Iwata S; Yumoto F; Fraser JS; DeGrado WF
    Proc Natl Acad Sci U S A; 2017 Dec; 114(51):13357-13362. PubMed ID: 28835537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Controlling influenza virus replication by inhibiting its proton channel.
    Pinto LH; Lamb RA
    Mol Biosyst; 2007 Jan; 3(1):18-23. PubMed ID: 17216051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proton-Induced Conformational and Hydration Dynamics in the Influenza A M2 Channel.
    Watkins LC; Liang R; Swanson JMJ; DeGrado WF; Voth GA
    J Am Chem Soc; 2019 Jul; 141(29):11667-11676. PubMed ID: 31264413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytoplasmic domain of influenza B virus BM2 protein plays critical roles in production of infectious virus.
    Imai M; Kawasaki K; Odagiri T
    J Virol; 2008 Jan; 82(2):728-39. PubMed ID: 17989175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequence-specific cleavage of BM2 gene transcript of influenza B virus by 10-23 catalytic motif containing DNA enzymes significantly inhibits viral RNA translation and replication.
    Kumar B; Kumar P; Rajput R; Saxena L; Daga MK; Khanna M
    Nucleic Acid Ther; 2013 Oct; 23(5):355-62. PubMed ID: 23971908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein structural defects enable pharmaceutical targeting while functionalizing the M2 proton channel.
    Fernández A
    Biochem Biophys Res Commun; 2019 Jun; 514(1):86-91. PubMed ID: 31023526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug inhibition and proton conduction mechanisms of the influenza a M2 proton channel.
    Gu R; Liu LA; Wei D
    Adv Exp Med Biol; 2015; 827():205-26. PubMed ID: 25387967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular dynamics calculations suggest a conduction mechanism for the M2 proton channel from influenza A virus.
    Khurana E; Dal Peraro M; DeVane R; Vemparala S; DeGrado WF; Klein ML
    Proc Natl Acad Sci U S A; 2009 Jan; 106(4):1069-74. PubMed ID: 19144924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoclonal antibody, but not synthetic peptide, targeting the ectodomain of influenza B virus M2 proton channel has antiviral activity.
    Wang Y; Xu H; Wu N; Shi H; Wang X; Wang T
    New Microbiol; 2010 Oct; 33(4):311-7. PubMed ID: 21213589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Water orientation and dynamics in the closed and open influenza B virus M2 proton channels.
    Gelenter MD; Mandala VS; Niesen MJM; Sharon DA; Dregni AJ; Willard AP; Hong M
    Commun Biol; 2021 Mar; 4(1):338. PubMed ID: 33712696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Viral M2 ion channel protein: a promising target for anti-influenza drug discovery.
    Moorthy NS; Poongavanam V; Pratheepa V
    Mini Rev Med Chem; 2014; 14(10):819-30. PubMed ID: 25342196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.